Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Merck's Anti-PD1 Melanoma Drugs Shrinks Tumors In Half of Patients
Merck's Anti-PD1 Melanoma Drugs Shrinks Tumors In Half of Patients
Merck's Anti-PD1 Melanoma Drugs Shrinks Tumors In Half of Patients
Submitted by
admin
on June 2, 2013 - 11:54am
Source:
The Street
News Tags:
Merck
labrolizumab
melanoma
Headline:
Merck's Anti-PD1 Melanoma Drugs Shrinks Tumors In Half of Patients
Do Not Allow Advertisers to Use My Personal information
